Ferrari; Guido

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ferrari; Guido.The latest application filed is for "optimized gp41-binding molecules and uses thereof".

Company Profile

2.4.8

Ferrari; Guido - Durham NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof Grant 11,421,031 - Koenig , et al. August 23, 2	2022-08-23
Optimized gp41-Binding Molecules and Uses Thereof App 20210246194 - Lam; Chia-Ying Kao ; et al.	2021-08-12
Mosaic Hiv-1 Envelopes To Induce Adcc Responses App 20210139544 - Korber; Bette ; et al.	2021-05-13
Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses Thereof App 20210095021 - Koenig; Scott ; et al.	2021-04-01
Bispecific Molecules Comprising An Hiv-1 Envelope Targeting Arm App 20200354439 - HAYNES; Barton F. ; et al.	2020-11-12
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof Grant 10,730,947 - Koenig , et al.	2020-08-04
Bispecific molecules comprising an HIV-1 envelope targeting arm Grant 10,717,778 - Haynes , et al.	2020-07-21
Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses Thereof App 20180155423 - Koenig; Scott ; et al.	2018-06-07
Bispecific Molecules Comprising An Hiv-1 Envelope Targeting Arm App 20180148497 - HAYNES; Barton F. ; et al.	2018-05-31
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof Grant 9,908,938 - Koenig , et al. March 6, 2	2018-03-06
Use Of Tetrahydroindazolylbenzamide And Tetrahydroindolylbenzamide Derivatives For The Treatment Of Human Immunodeficiency Virus (hiv) And Acquired Immune Deficiency Syndrome (aids) App 20160143884 - Orlemans; Everardus O.M. ; et al.	2016-05-26
Adcc-mediating Antibodies, Combinations And Uses Thereof App 20150239961 - Haynes; Barton F. ; et al.	2015-08-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.